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Background: Establishing the cognitive phenotype of psychotic symptoms in Alzheimer’s disease (AD)
could localise discrete pathology and target symptomatic treatment. This study aimed to establish
whether psychotic symptoms would be associated with poorer performance on neuropsychological tests
known to correlate with striatal dopaminergic function and to investigate whether these differences
would be attributed to the paranoid (persecutory delusions) or misidentiﬁcation (misidentiﬁcation phe-
nomena+/hallucinations) subtype.
Methods: Seventy patients with probable AD (34 psychotic and 36 nonpsychotic) were recruited to the
study. Analysis of covariance was used to compare motor speed and the rapid visual processing test of
sustained visual attention, after adjusting for potential confounding factors. Multivariate analyses were
used to compare performance across other cognitive domains. Signiﬁcant ﬁndings were explored by
separating patients on the basis of subtype.
Results: Rapid visual processing performance accuracy was reduced in patients with psychotic symp-
toms (F1,58=5.94, p=0.02) and differed signiﬁcantly across subtypes (F2,51=3.94, p=0.03), largely be-
cause of poorer performance in the misidentiﬁcation compared with nonpsychotic group. Multivariate
analyses (corrected for multiple comparisons) showed poorer performance on the incomplete letters
task in psychotic patients (F1,63=8.77, p=0.004) and across subtypes (F2,55=10.90, p<0.001), similarly
attributed to the misidentiﬁcation subtype.
Conclusions: These ﬁndings provide further support of the involvement of dopaminergic networks in
the psychosis endophenotype in AD and, in addition, implicate the ventral (temporo-occipital) pathway
in the misidentiﬁcation subtype. Future studies should investigate the early trajectory of neuropatholog-
ical change in vivo across psychosis subtypes.# 2015 The Authors. International Journal of Geriatric
Psychiatry published by John Wiley & Sons, Ltd.
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Introduction
Psychotic symptoms (delusions and hallucinations)
are highly prevalent in people with Alzheimer’s disease
(AD) (Ropacki and Jeste, 2005), manifest early in the
disease course and are associated with an accelerated
cognitive and functional decline (Koppel et al.,
2014b). Given the modest efﬁcacy and adverse effect
proﬁle associated with antipsychotic use in AD
(Schneider et al., 2006), there is a compelling clinical
need to elucidate the pathophysiology of psychotic
symptoms and identify novel therapeutic targets
(Geda et al., 2013). There is clear evidence that the
psychosis syndrome (delusions and/or hallucinations)
(Jeste and Finkel, 2000) represents a distinct
endophenotype of AD, with a heritability of around
60% (DeMichele-Sweet and Sweet, 2010). Attempts
to further categorise symptoms using factor analytical
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approaches have identiﬁed two broad subtypes (Cook
et al., 2003): a ‘paranoid’ subtype, which includes de-
lusions of persecution and/or abandonment, and a
‘misidentiﬁcation’ subtype, characterised by the pres-
ence of misidentiﬁcation phenomena and/or halluci-
nations. Research into the phenotypic correlates of
psychotic symptoms (predominantly delusions) has
provided some evidence to support this classiﬁcation
(Ismail et al., 2011; Reeves et al., 2012), as the mis-
identiﬁcation but not paranoid subtype has been asso-
ciated with more marked AD (neuroﬁbrillary tangle)
pathology postmortem (Ferman et al., 2013; Forstl
et al., 1994; Mukaetova-Ladinska et al., 1993) and
more global cognitive deﬁcits (indexed by lower
mini-mental state examination (MMSE) scores), in
clinical studies (Perez-Madrinan et al., 2004; Reeves
et al., 2012).
Establishing the neuropsychological proﬁle of psy-
chotic symptoms, and establishing any subtype depen-
dency in relation to the cognitive phenotype, could
help to localise discrete functional networks. There is
consistent evidence of greater executive and/or
‘frontal’ dysfunction in AD patients with psychotic
symptoms (Koppel et al., 2014b; Lee et al., 2009; Lee
et al., 2007; Paulsen et al., 2000a; Paulsen et al.,
2000b), including patients who present solely with
persecutory delusions (Nagata et al., 2009). Inconsis-
tent ﬁndings have however been reported across other
cognitive domains (Reeves et al., 2012). Differences in
the criteria used to deﬁne psychotic symptoms and a
lack of uniformity in the treatment of potential
confounding factors (e.g., age, MMSE, educational
level, psychotropic medication and affective symp-
toms) may be partly responsible for these discrepan-
cies. It is also possible that the neuropsychological
tests used were not sufﬁciently sensitive measures of
the cognitive factors associated with psychotic symp-
toms in AD.
In a previously published study, which used posi-
tron emission tomography to investigate cognitive, be-
havioural and motor correlates of striatal
dopaminergic function in AD, increased striatal D2/3
receptor availability was associated with the presence
of psychotic symptoms, which were predominantly
persecutory delusions (Reeves et al., 2009). These ﬁnd-
ings are comparable with data from patients with
schizophrenia and consistent with shared theories
regarding the involvement of corticostriatal dopami-
nergic networks in the origins of delusions
(Coltheart, 2010; Corlett et al., 2010; White and
Cummings, 1996). In the same sample, motor speed
and sustained visual attention (Reeves et al., 2010)
correlated signiﬁcantly with D2/3 receptor availability,
but the sample size was too small to meaningfully
compare performance in psychotic and nonpsychotic
groups. Given the preponderance of persecutory
delusions in the sample, it is unclear to what extent
these tests might be cognitive markers of the psychosis
endophenotype or, more speciﬁcally, the paranoid
subtype. The current study aimed to investigate the
neuropsychological correlates of psychotic symptoms
in psychotropic naive AD patients and to test the
following hypotheses:
(1) Performance on tests of motor speed and
sustained visual attention previously shown to
correlate with striatal dopaminergic function
would differ between psychotic and nonpsy-
chotic AD patients.
(2) When separated on the basis of paranoid (perse-
cutory) and misidentiﬁcation (misidentiﬁcation
phenomena and/or hallucinations) subtypes, dif-
ferences in performance between psychotic and
nonpsychotic patients would be largely accounted
for by the paranoid subtype.
A secondary aim was to establish the neuropsycho-
logical proﬁle of psychotic symptoms in AD and sim-
ilarly investigate subtype dependency of any signiﬁcant
ﬁndings.
Methods
Sample
Eighty patients with probable late-onset AD
(McKhann et al., 1984) were recruited from memory
services (n=66) and older adult community mental
health teams (n=11) within the South London and
Maudsley NHS Foundation Trust (SLaM) and a
Dementia Care Register, funded by the National
Institute for Health Research (NIHR) Biomedical
Research Centre (n=3). Exclusion criteria included
current or past history of neurological or psychiatric
illness, prescription of psychotropic medication
(including antipsychotics, antidepressants and anxio-
lytics), presence of parkinsonian symptoms (bradyki-
nesia, rigidity, facial masking or tremor) or other
features suggestive of a diagnosis of Lewy body
dementia (DLB) (McKeith et al., 2005). The study
was approved by The Joint South London and
Maudsley and Institute of Psychiatry NHS Research
Ethics Committee. Written informed consent was
obtained from each participant upon recruitment to
the study.
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Study design
Screening and assessment of psychotic symptoms
A modiﬁed version of the Neuropsychiatric Inventory
(NPI) (Cummings et al., 1994) was used to determine
the presence/absence and frequency/severity of past
and present psychotic symptoms (delusions and hallu-
cinations domains). Patients were classiﬁed as ‘psy-
chotic’ if their carer rated delusions or hallucinations
as ever having being present. Similar to our previously
published studies (Reeves et al., 2009; Reeves et al.,
2010), no threshold cut-off was used to deﬁne psy-
chotic symptoms. For the subtype analysis, delusions
of persecution/abandonment were deﬁned as the para-
noid subtype, and delusions that involved misidentiﬁ-
cation were combined with hallucinations to deﬁne
the misidentiﬁcation subtype (shown in Table 1), on
the basis of the classiﬁcation used by Cook et al. (Cook
et al., 2003). Patients who were currently experiencing,
or had experienced, both types of symptoms were de-
scribed as ‘mixed’. The Uniﬁed Parkinson’s Disease
Rating Scale (UPDRS) (Motor Examination) was used
to screen for the presence of parkinsonism (cut-off
score of 7) (Ballard et al., 1997), the MMSE (Folstein
et al., 1975) was used to assess global cognitive func-
tion (cut-off score of 10), the National Adult Reading
Test (Nelson, 1982) provided an estimation of
premorbid intellectual functioning and the Geriatric
Depression Scale-15 (Yesavage et al., 1982) was used
to exclude participants with clinically relevant depres-
sive symptoms (cut-off score of 6). Medication status
(prescription of cholinesterase inhibitors and/or
memantine) was documented at the time of screening
and controlled for in all statistical analyses.
Neuropsychological tests
Hypothesis-driven tests
Tests were chosen because of their previously docu-
mented associations with striatal dopaminergic (D2/3
receptor) function (Reeves et al., 2010) and included
the following: (i) rapid visual information processing
(RVP), a test of visual sustained attention from the
Cambridge Neuropsychological Test Automated Bat-
tery (CANTAB, Cambridge Cognition, UK) (Robbins
et al., 1994), which requires participants to press a
button whenever a speciﬁc three-digit sequence
(‘357’) appears on the screen, over a 3-min period;
(ii) motor screening (CANTAB), used as a screening
test, to establish whether participants were able to
see and touch a white box whenever it appears on
the computer screen and previously shown to corre-
late with D2/3 receptor function (Reeves et al.,
2010); and (iii) simple reaction time (CANTAB), a
more accurate measure of response time than the mo-
tor screening test.
Table 1 Description and classiﬁcation of psychotic symptoms (n = 34): Neuropsychiatric Inventory (NPI)
Domain Contenta
Ever experienced n
(%)
Currently experienced n
(%) Totalb
Delusions In danger/others are planning to hurt him or her P — 1 (1.4)
Others are stealing from him or her P 3 (4.3) 17 (24.3) 20 (28.6)
Spouse is having an affair P — 3 (4.3)
Family members plan to abandon him or her P — 5 (7.1)
Unwelcome guests are staying in his or her house M 4 (5.7) 6 (8.6) 10 (14.3)
His or her spouse or others are not who they claim
to be M
1 (1.4) 4 (5.7) 5 (7.1)
His or her house is not his or her own M 2 (2.9) 6 (8.6) 8 (11.4)
Television/magazine figures are present in his or her
home M
— —
Hallucinations He or she can hear voices M — 2 (2.9)
Talks to people who are not there M — 1 (1.4)
Seeing things not seen by others M 1 (1.4) 4 (5.7) 5 (7.1)
Smells odours not smelled by others — —
Feel things on his or her skin — —
Tastes without known cause — —
Any other unusual sensory experiences — —
P items included in the paranoid subtype.
M Items included in the misidentiﬁcation subtype.
aContent taken from items listed in the delusions and hallucinations domains of the NPI.
bEver experienced + currently experienced (only presented if different from currently experienced). Six patients were not currently experiencing
psychotic symptoms.
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Exploratory analysis
In order to establish a full neuropsychological proﬁle
of psychotic symptoms in AD, test measures were in-
cluded for the following domains: executive function
(digit span, semantic and phonemic ﬂuency and Hayling
Sentence Completion Task), memory (immediate verbal
recall, delayed verbal recall, delayed verbal recognition,
delayed visual recall and delayed visual recognition),
language (Boston Naming Test), constructional praxis
(the clock drawing task and a shape drawing task) and
visuoperceptual function [Visual Object and Space Per-
ception Battery (VOSP): incomplete letters, object deci-
sion, cube analysis, number location, plus a preliminary
screening test (shape detection) to determine whether a
participant has sufﬁcient visual acuity to complete the
other subtests]. Tests are described and referenced in
Table S1.
Statistical analyses
All statistical analyses were carried out using SPSS 19
(www.spss.com). Between-group differences in demo-
graphic data were analysed using independent samples
t-tests, Mann–Whitney U and chi-squared tests. Data
that failed to fulﬁl the assumption of normality were
transformed for subsequent analyses. Analysis of co-
variance (ANCOVA) was carried out for each of the
hypothesis-driven tests, with age, MMSE score and
years of education included as covariates and medica-
tion status as a ﬁxed factor. In the exploratory analysis,
multivariate analyses (MANCOVAs) were performed
where there were multiple dependent variables in each
cognitive domain and ANCOVA where there was only
one dependent variable. Where a MANCOVA resulted
in a signiﬁcant main effect (p<0.05), data were sub-
mitted to separate ANCOVAs and signiﬁcant differ-
ences determined using a Bonferroni-adjusted alpha
level. Fisher’s least signiﬁcant difference test was used
to correct for multiple pairwise comparisons in the
subtype analysis. Patients with mixed symptoms
(paranoid and misidentiﬁcation) were excluded from
the subtype analysis as the number of patients who
were able to complete the tests (six out of a total of
eight) was too small to meaningfully investigate.
Results
Demographic and clinical characteristics
Eighty patients were referred to the study, of which 10
were excluded on the basis of speciﬁed exclusion
criteria. Of the 70 participants (81.0+5.6 years; 32
men; MMSE=22.2+4.9) who participated in the
study, 34 (48.6%) of the sample were psychotic: 28
(82%) of the psychotic group were experiencing
symptoms at the time of assessment and 6 (8%) had
experienced symptoms at some point in the previous
6months. Psychotic symptoms were relatively mild
(delusions domain: mean frequency× severity
score=3.1+2.8; hallucinations domain: mean
frequency× severity score=2.3+1.7) and are detailed
in Table 1. Demographic and clinical data are shown
in Table 2. Psychotic patients were older (t68=2.67,
p=0.01) and showed more global behavioural distur-
bance, indexed by total NPI scores (Mann–Whitney
U, p<0.001) than the nonpsychotic group. There
were no signiﬁcant differences in educational level
Table 2 Demographic and clinical characteristics of psychotic and nonpsychotic patients
Nonpsychotic (n = 36) Psychotic (n = 34) Testdf, p-value
Mean (SD; range) age (years) 79.5 (5.5; 67–90) 82.8 (4.8; 75–93) t68 =2.67, p = 0.01
Number (%) men 16.4 (4.4) 16.4 (1.1) x2 = 0.05, df = 1, p = 0.82
Mean (SD; range) duration of illness 1.8 (1.3; 0.5–4.4) 2.0 (1.66; 0.1–5.6) t68 =0.43, p = 0.67
Mean (SD; range) years of education 10.0 (1.8; 6–13) 9.9 (1.4;7–13) t68 = 0.31, p = 0.76
Mean (SD; range) MMSE 23.5 (3.7; 14–28) 20.9 (5.7; 10–28) Mann–Whitney U, p = 0.07
Number (%) prescribed cholinesterase
inhibitor and/or memantine
32 (88.9) 27 (79.4) x2 = 1.19, df = 1, p = 0.28
Mean (SD; range) UPDRS score 0 0.3 (0.6; 0–3) Mann–Whitney U, p = 0.07
Mean (SD; range) NPI: Total 4.2 (4.9; 0–17) 15.5 (14.1; 1–73) Mann–Whitney U, p< 0.001
Mean (SD; range) NPI: Total (excluding
delusions and hallucinations domains)
4.2 (4.9; 0–17) 12.5 (12.5; 0–61) Mann–Whitney U, p< 0.001
SD, standard deviation; MMSE, mini-mental state examination; UPDRS: Uniﬁed Parkinson’s Disease Rating Scale (Motor Examination); NPI:
Neuropsychiatric Inventory.
Mean (SD) MMSE scores across subtypes [nonpsychotic = 23.5 + 3.7; paranoid = 22.1 + 5.3; misidentiﬁcation = 20.1 + 6.0; mixed = 20.0 (6.2)
(F3,69 = 2.25, p = 0.09)].
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(t68=0.31, p=0.76), illness duration (t68=0.43,
p=0.67) or medication status (x2=1.19, df=1,
p=0.28), but there was a trend for lower MMSE
scores in the psychotic group (Mann–Whitney U,
p=0.07). There was a trend for higher UPDRS scores
(Mann–Whitney U, p=0.07) in psychotic patients,
largely accounted for by a score on 3 in a single par-
ticipant who presented solely with delusions.
Hypothesis-driven analysis
Table 3 describes and compares performance on tests
of motor speed and sustained visual attention in psy-
chotic and nonpsychotic patients. There was no signif-
icant effect of psychotic symptoms on motor speed,
indexed by motor latency and simple reaction time
(F1,64=0.03, p=0.87; F1,64=0.62, p=0.43, respec-
tively). There was a signiﬁcant main effect of psychotic
symptoms on the RVP task (F1,58=5.94, p=0.02,
ηp2=0.09), indicating fewer correct responses in the
psychotic group. The subtype analysis (nonpsychotic,
paranoid and misidentiﬁcation) similarly showed sig-
niﬁcant between-group differences (F2,51=3.94,
p=0.03, ηp2=0.13). Post-hoc pairwise comparisons
showed that these differences were largely explained
by poorer performance in the misidentiﬁcation com-
pared with the nonpsychotic group (p=0.01). No
other between-group differences were found.
Exploratory analysis
Table 4 describes and compares performance in psy-
chotic and nonpsychotic patients across a range of
cognitive domains, using MANCOVA/ANCOVA and
controlling for potential confounding variables. There
was a signiﬁcant main effect of psychotic symptoms
on visuoperceptual performance, which included four
components of the VOSP (F4,60=3.75, p=0.009,
ηp2=0.20). ANCOVAs of individual VOSP compo-
nents (using a Bonferroni-adjusted alpha level of
p<0.0125) showed a signiﬁcant effect in relation to
incomplete letters (F1,63=8.77, p=0.004, ηp2=0.12).
MANCOVA/ANCOVA was not signiﬁcant for other
cognitive domains. When VOSP performance was
separated on the basis of subtype (nonpsychotic, para-
noid and misidentiﬁcation) (Table 5), a signiﬁcant
main effect was observed (F8,106=3.64, p=0.001,
ηp2=0.22). ANCOVA conducted on individual com-
ponents of the VOSP showed signiﬁcantly poorer per-
formance on incomplete letters performance
(F2,55=10.90, p<0.001, ηp2=0.28) and more moder-
ate effects in relation to cube analysis, which failed to
survive Bonferroni correction (Table 5). Post-hoc
pairwise comparisons showed lower incomplete letters
scores in the misidentiﬁcation group compared with
nonpsychotic (p<0.001) and paranoid (p=0.04)
groups. No other between-group differences were
found. Given the ﬁndings of differential RVP and
VOSP performance across subtypes, post-hoc analyses
were conducted across all cognitive domains, to inves-
tigate subtype dependency. No signiﬁcant effects were
found (executive function F10,100=0.68, p=0.74;
memory F10,104=0.40, p=0.94; language F2,55=0.39,
p=0.68; constructional praxis F4,108=0.55, p=0.70).
Discussion
The primary aim of the study was to establish if tests
previously shown to correlate with striatal dopaminer-
gic function would differentiate between psychotic and
nonpsychotic AD patients and to investigate subtype
dependency of any signiﬁcant ﬁndings. The ﬁnding of
impaired accuracy of RVP performance in psychotic
patients is consistent with our previous study, where
increased striatal D2/3 availability was associated both
with poorer RVP performance and the presence of
Table 3 Motor speed and rapid visual processing (RVP) in psychotic and nonpsychotic patients
Global Analysis Nonpsychotic (n = 36) Psychotic (n = 34) Fdf, p ηp
2
Motor latency (s) 1.4 (0.6) 1.5 (0.6) F1,64 = 0.03, p = 0.87 <0.001
Simple reaction time (s) 0.4 (0.1) 0.5 (0.1) F1,64 = 0.62, p = 0.43 0.01
RVP: number of correct
responsesa
19.1 (4.2) 16.4 (4.1) F1,58 = 5.94, p = 0.02 0.09
Subtype analysis Nonpsychotic (n = 34) Paranoid (n = 13) Misidentification (n = 11) Fdf, p
RVP 19.1 (4.2)b 16.6 (4.4) 14.7 (4.2) F2,51 = 3.94, p = 0.03 0.13
Separate analyses of covariance were carried out on each performance measure, adjusting for age, mini-mental state examination (x4) and educa-
tional level. Medication status was included as a ﬁxed factor.
aFour psychotic and two nonpsychotic patients were unable to complete the RVP task.
bPost-hoc pairwise comparison showed signiﬁcant difference (p = 0.01) between the misidentiﬁcation and nonpsychotic group.
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psychotic symptoms (Reeves et al., 2009; Reeves et al.,
2010). Our ﬁndings are also comparable with data on
young adults with schizophrenia spectrum disorders
(Cattapan-Ludewig et al., 2005; Hilti et al., 2010a)
and their nonaffected ﬁrst degree relatives (Hilti
et al., 2010b), in whom reduced RVP accuracy has been
described as a phenotypic marker, reﬂecting ‘impaired
context representation’ (Hilti et al., 2010b). The fact
that such differences were detectable in patients with
predominantly mild symptoms, some of whom were
not experiencing symptoms at the time of testing,
and who would not fulﬁl criteria for the psychosis syn-
drome (Jeste and Finkel, 2000) suggests that impaired
RVP accuracy may similarly be a trait marker of psy-
chosis proneness in AD.
Contrary to our prediction, there were no differ-
ences between psychotic and nonpsychotic patients
in measures of motor speed, which correlated highly
Table 4 Neuropsychological of psychotic symptoms: multivariate analysis across cognitive domains
Cognitive domain F, p, ηp
2 Nonpsychotic (n = 36) Psychotic (n = 34)
Executive function F5,59 = 0.9, p = 0.41, ηp
2 = 0.08 n = 35 n = 33
Semantic fluency (number of words) 23.5 (7.5) 19.5 (7.0)
Phonemic fluency (number of words) 26.7 (12.3) 23.0 (12.1)
Digit span 13.6 (2.9) 12.3 (2.6)
Hayling inhibition time (ms) 126.8 (65.2) 112.9 (53.0)
Hayling total errors 9.6 (3.7) 10.8 (3.5)
Memory F5,60 = 0.85, p = 0.52, ηp
2 = 0.07 n = 36 n = 34
Immediate verbal recall 10.2 (3.2) 11.2 (3.2)
Delayed verbal recall 1.2 (1.3) 1.3 (1.3)
Delayed visual recall 1.4 (0.4) 1.0 (0.4)
Delayed verbal recognition 15.4 (3.0) 16.2 (3.0)
Delayed visual recognition 17.4 (3.5) 16.9 (3.5)
Language F1,64 = 0.36, p = 0.55, ηp
2 = 0.01 n = 36 n = 34
Boston Naming Test 11.5 (2.6) 11.2 (2.6)
Constructional praxis F2,62 F = 1.46, p = 0.24, ηp
2 = 0.05 n = 35 n = 34
Total praxis score 9.1 (1.9) 8.3 (1.9)
Clock drawing task (scale 1–6) 3.2 (1.3) 3.5 (1.3)
Visuospatial perceptiona F4,60 = 3.75, p = 0.009, ηp
2 = 0.20 n = 36 n = 33
Incomplete letters F1,63 = 8.77, p = 0.004, ηp
2 = 0.12 18.2 (2.9) 15.5 (4.5)
Object decision F1,63 = 3.60, p = 0.06, ηp
2 = 0.05 15.5 (2.8) 13.7 (3.0)
Number location F1,63 = 1.56, p = 0.22, ηp
2 = 0.02 7.5 (2.5) 6.6 (3.1)
Cube analysis F1,63 = 0.02, p = 0.89, ηp
2
< 0.001 7.0 (2.5) 6.8 (2.7)
Mean (SD) values are shown. Transformations were as follows: delayed visual recall = log10(x + 1); incomplete letters = x
2.
F ratio, p-value and ηp
2 values are presented for each multivariate analysis of covariance, adjusting for age, educational level and mini-mental state
examination (x4). Medication status was included as a ﬁxed factor.
aF, p and ηp
2 values are shown for individual analysis of covariance (Bonferroni-adjusted alpha level of p< 0.0125 was applied).
Table 5 Rapid visual processing and visual object and space perception battery across subtypes
Neuropsychological test Nonpsychotic (n = 36) Paranoid (n = 14) Misidentification (n = 12) Fdf, p ηp
2
VOSP (MANCOVA) F8,106 = 3.64, p = 0.001 0.22
Incomplete letters 18.2 (1.4)* 16.6 (2.9)** 12.8 (2.2) F2,55 = 10.90, p< 0.001 0.28
Object decision 15.5 (2.8) 13.3 (3.4) 14.2 (1.7) F2,55 = 2.21, p = 0.12 0.07
Number location 7.5 (2.5) 6.6 (3.2) 5.3 (3.1) F2,55 = 1.87, p = 0.16 0.06
Cube analysis 7.0 (2.5) 7.8 (2.0) 4.9 (3.1) F2,55 = 3.92, p = 0.03 0.13
VOSP, Visual Object and Space Perception; MANCOVA, multivariate analysis of covariance.
Mean (standard deviation) scores for test performance measures are shown. F and p-values are presented for MANCOVA/analysis of covariance,
after adjusting for age, mini-mental state examination (x4) and educational level. Medication status was included as a ﬁxed factor.
Bonferroni-corrected alpha level of p< 0.0125 was applied to analysis of covariance for individual VOSP components.
Post-hoc pairwise comparisons show signiﬁcant differences compared with the misidentiﬁcation subtype:
Post-hoc subtype analysis was not signiﬁcant for other cognitive domains (executive function F10,100 = 0.68, p = 0.74; memory F10,104 = 0.40, p = 0.94;
language F2,55 = 0.39, p = 0.68; constructional praxis F4,108 = 0.55, p = 0.70).
*p< 0.001.
**p = 0.04.
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with dopaminergic function in our previous study.
One possible explanation for this is the differential in-
volvement of striatal subregions in attentional and
motor function. In our previous study, RVP perfor-
mance was associated with D2/3 receptor availability
in the associative striatum (caudate), a region that is
functionally connected with the dorsolateral prefron-
tal cortex and has a key role in cognitive control and
belief evaluation: In contrast, motor latency scores
were correlated with D2/3 receptor availability in the
sensorimotor striatum, which forms part of a func-
tional network primarily involved in movement coor-
dination (Reeves et al., 2009; Reeves et al., 2010).
The ﬁndings of the subtype analysis were at odds
with our original prediction, as the observed differ-
ences in RVP scores were explained by poorer perfor-
mance in the misidentiﬁcation subtype compared with
nonpsychotic patients. These differences were not ex-
plained by the trend towards lower MMSE scores in
the misidentiﬁcation group, as MMSE was controlled
for in the subtype analysis. The RVP has complex task
requirements, including visual recognition (the ability
to correctly identify numeric stimuli), selective and
sustained attention and working memory (holding a
3-digit sequence ‘online’). Functional imaging studies
have shown activation of a frontoparietal attentional
network during RVP performance and, as stimulus
speed is increased to make performance more effort-
ful, coactivation of regions involved in visual process-
ing (fusiform gyrus and lateral occipital cortex) (Coull
et al., 1996). Despite our use of an adapted version of
the RVP, which requires participants to respond to
only a single target sequence, patients generally found
the task more difﬁcult than other test measures in the
battery (four psychotic and two nonpsychotic patients
were unable to complete the test). Within the context
of ‘effortful’ RVP performance, it is possible that lower
scores in patients with the misidentiﬁcation subtype
are explained by the presence of additional deﬁcits in
visual recognition. The ﬁndings of the exploratory
analysis would support this suggestion, as the misiden-
tiﬁcation subtype were markedly impaired in their
performance on the incomplete letters task compared
with nonpsychotic and paranoid groups. Combined,
the current ﬁndings implicate impaired object pro-
cessing in the ventral (temporo-occipital) visual path-
way (Mishkin et al., 1983) in the misidentiﬁcation
subtype, particularly the lateral occipital cortex, which
contributes both to ﬁgural completion (ffytche and
Zeki, 1996) and RVP performance.
Impaired visual memory (Rey Osterreith) has been
previously reported by Perez-Madrinan et al. (2004) in
patients with the misidentiﬁcation subtype. However,
the extent of the difference across subtypes did not
achieve signiﬁcance after controlling forMMSE, and in-
terpretation of the ﬁndings was further limited by the
inclusion of patients with a range of diagnoses including
AD, DLB and vascular dementia. Other studies, which
have restricted their investigation to AD, have found
nodifferences in visuoperceptual function betweenpsy-
chotic and nonpsychotic patients. These negative ﬁnd-
ings may be explained by small sample sizes (n<18 in
psychotic group) (Lopez et al., 1991; Mentis et al.,
1995; Staff et al., 1999; Starkstein et al., 1994) or by their
use of tests, including Ravens Progressive Matrices and
Visual Form Discrimination, which are more complex
in their requirements, and thus less speciﬁc for the ven-
tral visual pathway, than the incomplete letters task.
The study was limited by the number of neuropsy-
chological tests included in the battery, which increased
the possibility of a type I error in the exploratory analy-
sis. However, this was balanced by the use of multivar-
iate analyses, which reduced the number of required
statistical comparisons, and by initially restricting the
analysis of subtype dependency to performance mea-
sures that differed signiﬁcantly between psychotic and
nonpsychotic groups. The extent of the difference in in-
complete letters scores between psychotic and nonpsy-
chotic patients (which survived Bonferroni correction)
and the fact that visual recognition has been implicated
by Perez-Madrinan et al. (2004) would argue against
this being a spurious ﬁnding. This will however need
to be replicated in future studies. The co-occurrence
of hallucinations and misidentiﬁcations in 7 of the 12
patients in the misidentiﬁcation subtype meant that it
was not possible to explore the speciﬁc contribution
of misidentiﬁcation phenomena to the aforementioned
ﬁndings. This is an important limitation and will need
to be further investigated in samples that are sufﬁciently
large to allow a meaningful investigation across all sub-
types, including those with mixed symptoms, in the
presence and absence of hallucinations.
The decision to have no threshold cut-off for NPI
scores to deﬁne delusions or hallucinations was based
on the ﬁndings of our previous imaging study, in
which signiﬁcantly higher striatal D2/3 receptor avail-
ability was found in patients with mild, transient psy-
chotic symptoms, who scored 1 or more on either the
delusions or hallucinations domain on the NPI. Al-
though this approach is consistent with a ‘continuum’
model of psychosis, it may have led to the inclusion of
‘false positives’ in the psychotic group.
The study was also limited by the absence of precise
data on illness duration, which was documented as
time since ﬁrst presentation to a memory service. As
a result, it was not included as a potential confounder
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in the analysis. A more detailed chronology of the ill-
ness, including time to onset of psychotic phenomena,
will be required in future studies. We cannot
completely rule out the possibility that patients with
the misidentiﬁcation subtype in the current sample
represent early, undiagnosed cases of DLB, given the
occurrence of visual hallucinations and misidentiﬁca-
tions at a relatively mild stage of disease (Ferman
et al., 2013), the fact that impaired VOSP performance
has been previously reported in DLB (Cagnin et al.,
2013) and the trend towards higher UPDRS scores in
the psychotic group. It is therefore possible that early
Lewy body pathology is mediating the association be-
tween the misidentiﬁcation subtype and tests of visual
attention/visuoperceptual function in the patients
studied. Against this is the absence of the broader def-
icits in visuospatial and visuoperceptual function that
are typically observed in DLB (Cagnin et al., 2013)
and the fact that UPDRS scores were comparable with
those previously reported in AD (Cagnin et al., 2013).
The absence of signiﬁcant differences between psy-
chotic and nonpsychotic groups across all other cogni-
tive domains is not wholly surprising, as previous
studies have reported largely negative ﬁndings after
adjusting for MMSE and other potential confounders
(Reeves et al., 2012). It is possible that the tests used
were not sufﬁciently sensitive markers of the cognitive
phenotype, and this is perhaps most relevant in relation
to tests of executive function, where scores on verbal
(semantic and phonemic) ﬂuency were lower in psy-
chotic patients (Table 4) but not signiﬁcantly so. Tests
that have been speciﬁcally designed to detect frontal
dysfunction within the context of cognitive impair-
ment, and which have been previously shown to differ-
entiate between psychotic and nonpsychotic AD
patients (Nagata et al., 2009; Paulsen et al., 2000a),
may have proved more informative. For example,
Nagata et al. (2009) found performance deﬁcits on the
Frontal Assessment Battery in psychotic AD patients
who were almost exclusively of the paranoid subtype.
The ﬁndings of Nagata et al. (2009) and Perez-
Madrinan et al. (2004) combined with the current study
would argue strongly for an investigation of subtype de-
pendency of phenotypic markers in future studies.
Contemporary models (Coltheart, 2010; Corlett
et al., 2010) that integrate neuropsychological and
associative learning theories have emphasised the im-
portance of perceptual expectations in the pathophysi-
ology of delusions and propose that visuoperceptual
deﬁcits, combined with disruption of corticostriatal net-
works, play an integral role in misidentiﬁcation delu-
sions. Our ﬁndings are also consistent with integrative
theories regarding the origins of visual hallucinations
within the context of neurodegenerative disease
(reviewed by Collerton and Taylor, 2013), which sug-
gest that deﬁcits in attentional control and perceptual
processing are necessary for visual misperceptions and
hallucinations to occur (Collerton et al., 2005;
Diederich et al., 2009; Shine et al., 2011). On the basis
of the present ﬁndings, it is tempting to speculate that
psychotic symptoms in AD are underpinned by disrup-
tion of the cholinergic/dopaminergic axis within
frontostriatal circuits, with additional pathology in the
ventral visual pathway in patients with the misidentiﬁ-
cation subtype. Postmortem studies have shown a
greater pathological (neuroﬁbrillary tangle) burden in
frontal cortical regions (Farber et al., 2000; Koppel
et al., 2014a; Murray et al., 2014). There is also evidence
of greater tau pathology in frontal (Ferman et al., 2013)
and limbic/paralimbic regions (Ferman et al., 2013;
Forstl et al., 1994; Mukaetova-Ladinska et al., 1993) in
AD patients with misidentiﬁcations, including
hippocampal/parahippocampal regions that are func-
tionally connected with the ventral visual pathway.
Whether these changes manifest early in the disease
course, and contribute to the development of misidenti-
ﬁcation symptoms, are yet to be established. Positron
emission tomography imaging techniques that selectively
target tau pathology are a potentially exciting avenue for
future research in this area, because they could be used to
explore the trajectory of early neuropathological change
in AD and its contribution to the psychosis phenotype.
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Key points
• The study aimed to establish the cognitive
phenotype of psychotic symptoms in
Alzheimer’s disease and, where ﬁndings were
signiﬁcant, to explore subtype dependency.
• Psychotic patients performed more poorly on the
rapid visual processing test of sustained attention
and the incomplete letters test from the Visual
Object and Space Perception Battery.
• When psychotic patients were separated on the basis
of ‘paranoid’ (persecutory) or ‘misidentiﬁcation’
(misidentiﬁcations and/or hallucinations) subtypes,
poorer performance was largely explained by the
misidentiﬁcation subtype.
• These ﬁndings implicate the ventral visual
pathway in the misidentiﬁcation subtype and
warrant further investigation in a larger sample.
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